Wells Fargo Downgrades Health Net (HNT) to Market Perform; Cutting Estimates After Q1 Miss
Tweet Send to a FriendGet Alerts HNT Hot Sheet
Price: $30.87 -0.23%
Rating Summary:
3 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 25 | New: 24
Rating Summary:
3 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 25 | New: 24
Trade HNT Now!
Wells Fargo downgraded Health Net (NYSE: HNT) from Outperform to Market Perform, price target lowered from $41-50 to $29-33.
Analyst, Peter Costa, said, "We believe Health Net's narrow network products and potential for growth in Medicare, Medicaid, and with dually eligible members in California position Health Net for improved performance going forward. However, its lack of visibility on medical cost represents a risk to this potential improved performance."
"Given the medical cost trend pressure in Q4 2011, which seems to have been obscured to the company due to the HIPAA 5010 regulation changes, which caused claims to be delayed, we are lowering our 2012 EPS estimate to $2.25 from $3.45. We are lowering our 2013 EPS estimate to $3.50 from $3.75, but now include some EPS from the likely growth of dual-eligible members in California."
For an analyst ratings summary and ratings history on Health Net click here. For more ratings news on Health Net click here.
Shares of Health Net closed at $36.32 yesterday, with a 52 week range of $20.51-$41.22.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Peter Costa, said, "We believe Health Net's narrow network products and potential for growth in Medicare, Medicaid, and with dually eligible members in California position Health Net for improved performance going forward. However, its lack of visibility on medical cost represents a risk to this potential improved performance."
"Given the medical cost trend pressure in Q4 2011, which seems to have been obscured to the company due to the HIPAA 5010 regulation changes, which caused claims to be delayed, we are lowering our 2012 EPS estimate to $2.25 from $3.45. We are lowering our 2013 EPS estimate to $3.50 from $3.75, but now include some EPS from the likely growth of dual-eligible members in California."
For an analyst ratings summary and ratings history on Health Net click here. For more ratings news on Health Net click here.
Shares of Health Net closed at $36.32 yesterday, with a 52 week range of $20.51-$41.22.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: UBS Downgrades Carnival (CCL) to Neutral; Worst May Not Be Behind
- Goldman Sachs Upgrades Meritor (MTOR) to Buy
- UPDATE: Sterne Agee Downgrades Beazer Homes (BZH) to Neutral
Create E-mail Alert Related Categories
Analyst EPS Change, Analyst EPS View, Analyst PT Change, DowngradesRelated Entities
Wells Fargo
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
